InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,092.40
(
0.53%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.06
(
-0.58%
)
Bitcoin
66,374.26
(
-0.05%
)
Post# of 251581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bUrRpPPP! post# 203823

Monday, 09/26/2016 9:40:18 AM

Monday, September 26, 2016 9:40:18 AM

Post# of 251581
PTIE-62%/DRRX-29% on CRL* for Remoxy:

http://finance.yahoo.com/news/complete-response-letter-remoxy-110000587.html?soc_src=social-sh&soc_trk=tw

The CRL specifies additional actions that are needed in order to obtain approval of REMOXY ER with label claims against three routes of abuse (i.e., injection, inhalation and snorting). These actions may take approximately a year to conduct and may cost approximately $5MM…

Abuse deterrence is the raison d’être of Remoxy, so the product would have little value without the aforementioned label claims.

No CC.

*This is the third CRL for Remoxy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up